Accurate determination of epitope for antibodies with unknown 3D structures.
Antibodies, Monoclonal, Humanized
/ chemistry
Antigens
/ genetics
Binding Sites, Antibody
Epitope Mapping
Epitopes
ErbB Receptors
/ immunology
HEK293 Cells
Humans
Interleukin-4 Receptor alpha Subunit
/ genetics
Molecular Docking Simulation
Mutation
Protein Binding
Protein Conformation
Structure-Activity Relationship
Antibody
Epitope mapping
artificial intelligence
bioinformatics
dupilimumab
epitope binning
Journal
mAbs
ISSN: 1942-0870
Titre abrégé: MAbs
Pays: United States
ID NLM: 101479829
Informations de publication
Date de publication:
Historique:
entrez:
25
8
2021
pubmed:
26
8
2021
medline:
20
1
2022
Statut:
ppublish
Résumé
MAbTope is a docking-based method for the determination of epitopes. It has been used to successfully determine the epitopes of antibodies with known 3D structures. However, during the antibody discovery process, this structural information is rarely available. Although we already have evidence that homology models of antibodies could be used instead of their 3D structure, the choice of the template, the methodology for homology modeling and the resulting performance still have to be clarified. Here, we show that MAbTope has the same performance when working with homology models of the antibodies as compared to crystallographic structures. Moreover, we show that even low-quality models can be used. We applied MAbTope to determine the epitope of dupilumab, an anti- interleukin 4 receptor alpha subunit therapeutic antibody of unknown 3D structure, that we validated experimentally. Finally, we show how the MAbTope-determined epitopes for a series of antibodies targeting the same protein can be used to predict competitions, and demonstrate the accuracy with an experimentally validated example.3D: three-dimensionalRMSD: root mean square deviationCDR: complementary-determining regionCPU: central processing unitsVH: heavy chain variable regionVL: light chain variable regionscFv: single-chain variable fragmentsVHH: single-chain antibody variable regionIL4Rα: Interleukin 4 receptor alpha chainSPR: surface plasmon resonancePDB: protein data bankHEK293: Human embryonic kidney 293 cellsEDTA: Ethylenediaminetetraacetic acidFBS: Fetal bovine serumANOVA: Analysis of varianceEGFR: Epidermal growth factor receptorPE: PhycoerythrinAPC: AllophycocyaninFSC: forward scatterSSC: side scatterWT: wild typeKeywords: MAbTope, Epitope Mapping, Molecular docking, Antibody modeling, Antibody-antigen docking.
Identifiants
pubmed: 34432559
doi: 10.1080/19420862.2021.1961349
pmc: PMC8405158
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Antigens
0
Epitopes
0
Interleukin-4 Receptor alpha Subunit
0
necitumumab
2BT4C47RUI
dupilumab
420K487FSG
EGFR protein, human
EC 2.7.10.1
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1961349Références
Eur J Biochem. 1984 Nov 15;145(1):1-20
pubmed: 6208027
Methods. 1996 Jun;9(3):465-72
pubmed: 8812702
Nucleic Acids Res. 2016 Jul 8;44(W1):W474-8
pubmed: 27131379
Int J Mol Sci. 2011 Jan 05;12(1):226-51
pubmed: 21339984
PLoS One. 2014 Dec 11;9(12):e114691
pubmed: 25502211
Immunochemistry. 1978 Aug;15(8):609-10
pubmed: 83294
Bioinformatics. 2008 Jun 15;24(12):1459-60
pubmed: 18443018
MAbs. 2013 Mar-Apr;5(2):270-8
pubmed: 23575269
J Thromb Haemost. 2017 Oct;15(10):2065-2075
pubmed: 28771917
MAbs. 2017 Jan;9(1):29-42
pubmed: 27748644
Comput Struct Biotechnol J. 2017 Feb 01;15:222-231
pubmed: 28228926
PLoS One. 2014 Mar 20;9(3):e92451
pubmed: 24651868
Proteins. 2011 Nov;79(11):3050-66
pubmed: 21935986
Protein Sci. 2005 Feb;14(2):278-83
pubmed: 15659362
J Biomol NMR. 2014 Feb;58(2):141-7
pubmed: 24435566
Nucleic Acids Res. 2015 May 26;43(10):5221-35
pubmed: 25901030
BMC Bioinformatics. 2008 Dec 02;9:514
pubmed: 19055730
Sci Rep. 2019 May 23;9(1):7772
pubmed: 31123339
Proteins. 2003 Jul 1;52(1):98-106
pubmed: 12784374
Cell. 1999 Apr 16;97(2):271-81
pubmed: 10219247
Proteins. 1997 Oct;29(2):161-71
pubmed: 9329081
J Biol Chem. 2012 Jan 6;287(2):1269-78
pubmed: 22110136
Cell. 1990 May 18;61(4):553-6
pubmed: 1693095
J Immunol. 2018 Nov 15;201(10):3096-3105
pubmed: 30322966
J Immunol. 2017 Jan 1;198(1):505-515
pubmed: 27872211
Mol Immunol. 2016 Sep;77:126-31
pubmed: 27497837
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
Bioinformatics. 2009 Oct 1;25(19):2544-51
pubmed: 19620099
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Protein Sci. 2006 Nov;15(11):2507-24
pubmed: 17075131
Protein Eng Des Sel. 2010 Jun;23(6):441-8
pubmed: 20304974
J Gen Virol. 2015 Jun;96(Pt 6):1478-1483
pubmed: 25667320
Structure. 1996 Feb 15;4(2):135-45
pubmed: 8805520
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W96-9
pubmed: 15215358
BMC Bioinformatics. 2009 Sep 14;10:287
pubmed: 19751513
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W445-9
pubmed: 20444869
Bioinformatics. 2014 Aug 15;30(16):2288-94
pubmed: 24753488
Toxins (Basel). 2011 Nov;3(11):1433-52
pubmed: 22174979
PLoS One. 2011;6(12):e29104
pubmed: 22194998
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2129-34
pubmed: 23341632
Sci Rep. 2015 Jun 01;5:10760
pubmed: 26030356
Immunity. 2017 Dec 19;47(6):1197-1209.e10
pubmed: 29195810
J Immunol Res. 2016;2016:6760830
pubmed: 28127568
Protein Eng Des Sel. 2013 Oct;26(10):611-20
pubmed: 23708320
PLoS One. 2017 May 18;12(5):e0177923
pubmed: 28542300
Proteins. 2014 Aug;82(8):1553-62
pubmed: 24668560
Protein Sci. 2006 Nov;15(11):2558-67
pubmed: 17001032
Mol Immunol. 2008 Jul;45(12):3477-89
pubmed: 18023478
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
FASEB J. 2018 Mar;32(3):1154-1169
pubmed: 29084767
Nat Protoc. 2017 Feb;12(2):401-416
pubmed: 28125104